Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
361343-19-3CN1CCN(c2ccccc2/C=C2\SCCN(c3ccc(Cl)c(Cl)c3)C2=O)CC1LHYMPSWMHXUWSK-STZFKDTASA-N361343-19-3DTXSID7047277CHEMBL3185463VerwendenElzasonan is a selective 5-hydroxytryptamine 1B receptor antagonist that was developed by Pfizer (and then later discontinued in 2008) to treat patients with major depressive disorder and obsessive compulsive disorder.
Wird geladen…